Quantitative myocardial and blood T 1 have recently achieved clinical utility in numerous
pathologies, as they provide non-invasive tissue characterization with the potential to …

Myocardial native T1 and extracellular volume fraction (ECV) mapping have emerged as
cardiac magnetic resonance biomarkers providing unique insight into cardiac …

Myocardial T1 mapping by cardiovascular magnetic resonance (CMR) is a key emerging
biomarker for quantification of myocardial disease. Native myocardial T1 changes with fat …

While cardiovascular magnetic resonance (MR) has become the noninvasive tool of choice
for the assessment of myocardial viability and for the detection of acute myocardial edema …

Heart failure (HF) is a major and growing cause of morbidity and mortality. Despite initial
successes, there have been few recent therapeutic advances. A better understanding of HF …

Rapid innovations in cardiovascular magnetic resonance (CMR) now permit the routine
acquisition of quantitative measures of myocardial and blood T1 which are key tissue …

Cardiovascular magnetic resonance is a well-established tool for the quantification of focal
fibrosis. With the introduction of T1 mapping, diffuse myocardial processes can be detected …

Non-invasive identification and differentiation of myocardial diseases represents the primary
objectives of cardiac magnetic resonance (CMR) longitudinal relaxation time (T1) and …

Abstract Cardiovascular Magnetic Resonance is increasingly used to differentiate the
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …

Cardiovascular magnetic resonance (CMR) is a versatile imaging modality that enables
aetiological assessment and provides additional information to that of standard …